Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications
CA 2474800 A1 · Owner: Schwab, Matthias · Inventors: Schaffeler, Elke; Schwab, Matthias
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to a polymorphic TPMT polynucleotide. Moreover the invention relates to genes or vectors comprising the polynucleotides of the invention and to a host cell genetically engineered with the polynucleotide or gene of the invention. Further the invention relates to , methods for producing molecular variant polypeptides or fragments thereof methods for producing cells capable of expressing a molecular variant polypeptide and to a polypeptide or fragment thereof encoded by the polynucleotide or the gene of the invention or which is obtainable by the method or from the cells produced by the method of the invention. Furthermore the invention relates to an antibody …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 4, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 4, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 4, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.